Zobrazeno 1 - 10
of 3 131
pro vyhledávání: '"A L Crombie"'
Autor:
Fen Zhu, Jennifer L. Crombie, Wei Ni, Nguyet-Minh Hoang, Swati Garg, Liam Hackett, Stephen J. F. Chong, Mary C. Collins, Lixin Rui, James Griffin, Matthew S. Davids
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Despite recent advances in the therapy of diffuse large B-cell lymphoma (DLBCL), many patients are still not cured. Therefore, new therapeutic strategies are needed. The anti-apoptotic B-cell lymphoma 2 (BCL2) gene is commonly dysregulated in DLBCL d
Externí odkaz:
https://doaj.org/article/8b0191ebd1284f62ab563c4cfef6f73e
Autor:
Jennifer L. Crombie, Caron A. Jacobson, Robert Redd, Geoffrey Shouse, Alex F. Herrera, Victor A. Chow, Jordan Gauthier, Erin Mullane, Kirk Cahill, Justin Kline, Jason Romancik, Jonathon B. Cohen, Anna Saucier, Roch Houot, Philippe Armand, Brian Hess
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
Externí odkaz:
https://doaj.org/article/5acdfcb9d33441d58498adc67547a25c
Autor:
Matthew J. Frigault, Philippe Armand, Robert A. Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Alex F. Herrera, Parastoo Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreife O. Odejide, Arnold S. Freedman, Austin I. Kim, Jennifer L. Crombie, Caron A. Jacobson, Eric D. Jacobsen, Jeffrey L. Wong, Jad Bsat, Sanjay S. Patel, Jerome Ritz, Scott J. Rodig, Margaret A. Shipp, Yi-Bin Chen, Robin M. Joyce
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 122-126 (2020)
Abstract: Disease relapse remains the leading cause of failure after autologous stem cell transplantation (ASCT) for patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). We conducted a phase 2, multicenter, single-arm study of
Externí odkaz:
https://doaj.org/article/6dcead3a5e7b4235ab3757f5129bfa75
Autor:
Jennifer L. Crombie, Ann S. LaCasce
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting up to 90% of the population. EBV was first identified as an oncogenic virus in a Burkitt lymphoma cell line, though subsequently has been found to drive a variety of malignancies, includ
Externí odkaz:
https://doaj.org/article/0653d0b370e44b75a375345c4551f0e4
Autor:
David Qualls, Michael J Buege, Phuong Dao, Paolo F. Caimi, Sarah C. Rutherford, Graham Wehmeyer, Jason T. Romancik, Lori A. Leslie, Mwanasha H. Merrill, Jennifer L. Crombie, Behzad Amoozgar, Brad S. Kahl, David A. Bond, Kami J. Maddocks, Michelle Okwali, Venkatraman Seshan, Gilles Salles, Connie Lee Batlevi
Publikováno v:
Blood. 140:787-789
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8041d64184ced7ea7de50bcb9aba9202
https://doi.org/10.1182/blood-2022-167620
https://doi.org/10.1182/blood-2022-167620
Autor:
Reid W Merryman, Robert A. Redd, Arnold S. Freedman, Inhye E. Ahn, Jennifer R. Brown, Jennifer L. Crombie, Matthew S. Davids, David C. Fisher, Eric D Jacobsen, Austin I. Kim, Ann S. LaCasce, Samuel Ng, Oreofe O. Odejide, Erin Michelle Parry, Iris Isufi, Justin Kline, Jonathon B. Cohen, Neha Mehta-Shah, Nancy L. Bartlett, Matthew Mei, Philippe Armand, Caron A. Jacobson
Publikováno v:
Blood. 140:6531-6533
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd836d7ae721e6de053d10547e7111ee
https://doi.org/10.1182/blood-2022-159823
https://doi.org/10.1182/blood-2022-159823
Autor:
Alex F. Herrera, Lu Chen, Jennifer L. Crombie, Jonathon B. Cohen, Ranjana H. Advani, Ann S. LaCasce, Leslie L. Popplewell, Sandrine Puverel, Lacolle Peters, Shari Daniels, James Godfrey, Geoffrey Shouse, Matthew Mei, Swetha Kambhampati, L. Elizabeth Budde, Liana Nikolaenko, Steven T. Rosen, Larry W. Kwak, Stephen J Forman, Matthew J. Matasar
Publikováno v:
Blood. 140:1065-1067
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b97da1aed7a537c12acb43e84b8dc3b
https://doi.org/10.1182/blood-2022-165699
https://doi.org/10.1182/blood-2022-165699
Autor:
Rajat Bannerji, Jon E Arnason, Ranjana H Advani, Jennifer R Brown, John N Allan, Stephen M Ansell, Jeffrey A Barnes, Susan M O'Brien, Julio C Chávez, Johannes Duell, Andreas Rosenwald, Jennifer L Crombie, Melanie Ufkin, Jingjin Li, Min Zhu, Srikanth R Ambati, Aafia Chaudhry, Israel Lowy, Max S Topp
Publikováno v:
The Lancet Haematology. 9:e327-e339
Odronextamab is a hinge-stabilised, fully human IgG4-based CD20 × CD3 bispecific antibody that binds CD3 on T cells and CD20 on B cells. We aimed to evaluate the safety and antitumour activity of odronextamab in patients with relapsed or refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c7cea0a7b2e4936015a8f286ba40f6
https://doi.org/10.1016/s2352-3026(22)00072-2
https://doi.org/10.1016/s2352-3026(22)00072-2
Autor:
Jeffrey W Craig, Michael J Mina, Jennifer L Crombie, Ann S LaCasce, David M Weinstock, Geraldine S Pinkus, Olga Pozdnyakova
Publikováno v:
PLoS ONE, Vol 13, Iss 7, p e0199708 (2018)
"Double-hit" and "double-expressor" lymphomas represent distinct but overlapping subsets of aggressive B-cell non-Hodgkin lymphoma. The high rates of bone marrow involvement by these lymphomas pose a major therapeutic challenge due to the chemotherap
Externí odkaz:
https://doaj.org/article/a61f51179fe94063989c39e4b824833a
Autor:
Austin I. Kim, Caron A. Jacobson, Zixu Wang, Ann S. LaCasce, Samantha Pazienza, Jessica Lowney, Jennifer R. Brown, Matthew S. Davids, Jennifer L. Crombie, Matthew Weinstock, David C. Fisher, Svitlana Tyekucheva, Jon E. Arnason, Philippe Armand, Josie Montegaard, Samuel Y. Ng, Benjamin L. Lampson, Victoria Patterson
Publikováno v:
The Lancet Oncology. 22:1391-1402
Both continuous therapy with acalabrutinib and fixed-duration therapy with venetoclax-obinutuzumab are effective for previously untreated chronic lymphocytic leukaemia. We hypothesised that frontline time-limited, minimal residual disease (MRD)-guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8fbe0b0a6328ba157009a8ae5a8c103
https://doi.org/10.1016/s1470-2045(21)00455-1
https://doi.org/10.1016/s1470-2045(21)00455-1